<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02777216</url>
  </required_header>
  <id_info>
    <org_study_id>167CLP</org_study_id>
    <nct_id>NCT02777216</nct_id>
  </id_info>
  <brief_title>ConfidenHT System for Diagnostic Electrical Mapping of Renal Nerves</brief_title>
  <acronym>RDN</acronym>
  <official_title>ConfidenHTTM System Safety and Performance of Diagnostic Electrical Mapping of Renal Nerves in Hypertensive Patients and/or Potential Candidates for a Renal Sympathetic Denervation (RDN) Procedure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rainbow Medical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rainbow Medical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the safety and performance of the ConfidenHT System
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To evaluate the safety and performance of the ConfidenHT System for diagnostic mapping of
      renal nerves; functional distribution of renal nerves and the effect of renal nerve
      stimulation on the blood pressure
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 2016</start_date>
  <completion_date type="Actual">December 2017</completion_date>
  <primary_completion_date type="Actual">November 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence of serious adverse events (system and/or procedure related events)</measure>
    <time_frame>3 months</time_frame>
    <description>The incidence of serious adverse events (system and/or procedure related events)</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>ConfidenHT system</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ConfidenHT system</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ConfidenHT system</intervention_name>
    <description>ConfidenHT Medical system</description>
    <arm_group_label>ConfidenHT system</arm_group_label>
    <other_name>ConfidenHT Medical system</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Signed written informed consent.

          2. Age &gt;18 years and &lt;75.

          3. Either:

               1. Hypertensive patients planned to undergo elective cardiac catheterization

               2. Potential candidates for renal sympathetic denervation

          4. Main renal artery with diameter ≥ 4.0mm.

          5. Glomerular Filtration Rate (GFR) &gt;45 mL/min

          6. A patient who is mentally competent with the ability to understand and comply with the
             requirements of the study.

          7. The patient agrees to attend all follow-up evaluations and is willing to complete
             required exams and tests.

          8. Female patients with childbearing potential must agree:

               -  to use a valid method of contraception (oral contraceptives, intrauterine device,
                  subcutaneous contraceptive implant, vaginal ring)

               -  to perform a pregnancy test

        Exclusion criteria:

          1. Previous participation in another study with any investigational drug or device within
             the past 30 days.

          2. Relevant renal artery disease (% diameter stenosis&gt;30%, aneurysm or fibromuscular
             dysplasia).

          3. Known secondary causes of hypertension.

          4. The patient has a life expectancy ≤ 12 months.

          5. The patient has undergone prior renal denervation, renal stenting, and/or abdominal
             aortic stent grafts.

          6. The patient has chronic oxygen use other than nocturnal support for sleep apnea.

          7. The patient has type I diabetes mellitus.

          8. The patient has had a previous organ transplant or is awaiting a renal transplant.

          9. Active implantable medical device (e.g. ICD or CRT-D; neuromodulator/spinal
             stimulator; baroreflex stimulator).

         10. The patient has triple ipsilateral artery ostia.

         11. Moderate to severe valvular heart disease.

         12. The patient has other concomitant conditions that may adversely affect the patient or
             the study outcome.

         13. Female who is pregnant, nursing or planning to become pregnant.

         14. Documented contraindication or allergy to contrast medium not amenable to treatment.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kostas Tsioufis, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hippocratio Hospital, Athens, Greece</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hippocratio Hospital</name>
      <address>
        <city>Athens</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>EMC</name>
      <address>
        <city>Rotterdam</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>UMC</name>
      <address>
        <city>Utrecht</city>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 17, 2016</study_first_submitted>
  <study_first_submitted_qc>May 17, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 19, 2016</study_first_posted>
  <last_update_submitted>February 22, 2018</last_update_submitted>
  <last_update_submitted_qc>February 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 26, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>RDN</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

